Trinity Capital Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Trinity Capital Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-03-31 | 2023-09-30 | 2022-06-30 | 2022-03-31 | 2021-06-30 | 2021-03-31 | 2020-08-12 | 2020-06-30 | 2020-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| cash flows provided by/(used in) operating activities: | |||||||||
| net increase/(decrease) in net assets resulting from operations | 14,508,000 | 75,976,000 | -7,722,000 | -9,065,000 | 24,706,000 | 25,324,000 | |||
| adjustments to reconcile net increase/(decrease) in net assets resulting from operation to net cash provided by/(used in) operating activities: | |||||||||
| purchase of investments, net of deferred fees | -240,700,000 | 46,743,000 | -192,436,000 | -221,179,000 | -121,538,000 | -86,694,000 | |||
| proceeds from sales and paydowns of investments | 148,541,000 | 159,567,000 | 44,641,000 | 158,775,000 | 79,894,000 | 66,985,000 | 36,493,000 | 37,682,000 | 44,469,000 |
| net change in unrealized appreciation/(depreciation) from investments, net of third party participation | 12,000,000 | -114,337,000 | 13,820,000 | 77,318,000 | |||||
| net realized gain/(loss) from investments | -1,351,000 | 71,871,000 | 9,617,000 | -52,644,000 | -1,995,000 | -2,595,000 | |||
| accretion of original issue discounts and end of term payments on investments | -7,172,000 | -8,385,000 | -7,368,000 | -8,148,000 | -5,686,000 | -4,593,000 | -2,761,000 | ||
| amortization of deferred financing costs | 1,075,000 | 1,559,000 | 845,000 | 808,000 | 920,000 | 917,000 | 766,000 | 750,000 | 666,000 |
| stock-based compensation | 2,459,000 | 911,000 | |||||||
| change in operating assets and liabilities | |||||||||
| (increase)/decrease in interest receivable | -2,106,000 | 2,079,000 | -2,118,000 | -931,000 | -141,000 | -456,000 | |||
| (increase)/decrease in other assets | -872,000 | -781,000 | -363,000 | -1,960,000 | -2,389,000 | 32,000 | |||
| increase/(decrease) in security deposits | -1,173,000 | -2,311,000 | 966,000 | 709,000 | |||||
| increase/(decrease) in accounts payable, accrued expenses and other liabilities | -6,610,000 | -2,989,000 | -200,000 | 1,330,000 | |||||
| net cash provided by/(used in) operating activities | -81,401,000 | 235,819,000 | -143,348,000 | -52,366,000 | -35,171,000 | -19,728,000 | |||
| cash flows provided by/(used in) investing activities: | |||||||||
| disposal/(acquisition) of fixed assets | -33,000 | -2,243,000 | -36,000 | 60,000 | |||||
| net cash provided by/(used in) investing activities | -33,000 | -2,243,000 | -36,000 | 60,000 | |||||
| cash flows provided by/(used in) financing activities | |||||||||
| issuance of common stock, net of issuance costs | 24,240,000 | ||||||||
| stock repurchase and cancellation of shares, net of costs | |||||||||
| retirement of employee shares | -1,582,000 | ||||||||
| cash distributions paid | -22,821,000 | -8,750,000 | |||||||
| issuance of debt, net of issuance costs | 111,803,000 | ||||||||
| borrowings under credit facilities | 148,000,000 | 31,000,000 | 116,000,000 | 68,000,000 | |||||
| repayments under credit facilities | -171,000,000 | -25,000,000 | |||||||
| net cash provided by/(used in) financing activities | 88,640,000 | -203,442,000 | 127,926,000 | 34,248,000 | 18,683,000 | 10,402,000 | |||
| net increase/(decrease) in cash, cash equivalents and restricted cash | 7,206,000 | -15,458,000 | -18,058,000 | -16,820,000 | -9,816,000 | ||||
| cash, cash equivalents and restricted cash at beginning of period | 4,761,000 | 0 | 46,742,000 | 0 | 61,101,000 | ||||
| cash, cash equivalents and restricted cash at end of period | 11,967,000 | -15,458,000 | 28,684,000 | -16,820,000 | 51,285,000 | 14,253,000 | -41,084,000 | 79,485,000 | |
| (increase)/decrease in receivable from sale of investments | 1,710,000 | ||||||||
| issuance of common stock net of costs | |||||||||
| stock repurchase and cancellation of shares net of costs | |||||||||
| issuance of debt | |||||||||
| debt issuance cost paid | |||||||||
| net increase/(decrease) in cash, cash equivalents | |||||||||
| cash, cash equivalents at beginning of period | |||||||||
| cash, cash equivalents at end of period | |||||||||
| adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash provided by/(used in) operating activities: | |||||||||
| | |||||||||
| issuance of common stock | 0 | 112,088,000 | 0 | 0 | 125,000,000 | ||||
| common stock issuance costs | 0 | -7,880,000 | 0 | 81,000 | -10,610,000 | ||||
| debt issuance costs | |||||||||
| supplemental and non-cash investing and financing activities: | |||||||||
| cash paid for interest | 5,603,000 | 2,629,000 | 4,200,000 | 3,137,000 | 2,873,000 | 3,582,000 | |||
| accrued but unpaid distributions | 15,389,000 | 286,000 | 7,396,000 | ||||||
| distributions reinvested | 1,053,000 | ||||||||
| income tax, including excise tax, paid | 310,000 | ||||||||
| change to net assets related to adoption of asu 2020-06 | |||||||||
| costs related to the acquisition of trinity capital holdings and legacy funds | 0 | 0 | 15,586,000 | ||||||
| share-based compensation | |||||||||
| (increase)/decrease in prepaid expenses | |||||||||
| increase/(decrease) in due to related party | |||||||||
| formation transactions of legacy funds, net of cash acquired | 0 | 0 | -89,515,000 | ||||||
| acquisition of trinity capital holdings | 0 | 0 | -2,211,000 | ||||||
| acquisition of fixed assets | -332,000 | -490,000 | -27,000 | -24,000 | -10,000 | ||||
| proceeds from issuance of 2025 notes | |||||||||
| financing costs paid related to 2025 notes | |||||||||
| proceeds from issuance of 2026 notes | |||||||||
| financing costs paid related to 2026 notes | |||||||||
| proceeds under credit facility | |||||||||
| repayments under credit facility | 0 | -90,000,000 | 0 | -25,000,000 | -60,000,000 | ||||
| financing costs paid related to credit facility | -243,000 | -5,000 | -3,735,000 | ||||||
| shares issued to trinity capital holdings | 0 | 0 | 8,000,000 | ||||||
| assumption of severance liability | 0 | 0 | 3,508,000 | ||||||
| shares issued to the legacy investors as part of the formation transactions | 0 | 0 | 137,748,000 | ||||||
| value of shares issued in connection with the distribution reinvestment plan | 1,134,000 | 1,141,000 | |||||||
| non-cash settlement of investments | 596,000 | ||||||||
| adjustments to reconcile net decrease in net assets resulting from operations to net cash provided by/(used in) operating activities: | |||||||||
| net change in unrealized depreciation from investments, net of third party participation | -15,193,000 | ||||||||
| depreciation of fixed assets | 16,000 | 13,000 | |||||||
| increase/(decrease) in accounts payable and accrued liabilities | -3,507,000 | ||||||||
| increase/(decrease) in other liabilities | 1,143,000 | ||||||||
| net cash from investing activities | -490,000 | -27,000 | -24,000 | -91,736,000 | |||||
| distributions paid, net of stock issued under drip of 1,141 and 0, respectively | |||||||||
| cash flows from operating activities: | |||||||||
| net decrease in net assets resulting from operations | 12,334,000 | ||||||||
| adjustments to reconcile net decrease in net assets resulting from operations to net cash from operating activities: | |||||||||
| purchase of investments | -36,002,000 | -53,764,000 | -47,739,000 | ||||||
| net change in unrealized depreciation from investments | -8,279,000 | -2,162,000 | 24,277,000 | ||||||
| increase in interest receivable | 24,000 | -15,000 | -2,054,000 | ||||||
| increase in prepaid expenses | |||||||||
| increase in other assets | 55,000 | 277,000 | -582,000 | ||||||
| increase in accounts payable and accrued liabilities | 1,109,000 | -774,000 | 3,069,000 | ||||||
| decrease in due to related party | 0 | 0 | -1,058,000 | ||||||
| increase in other liabilities | 843,000 | 117,000 | 2,093,000 | ||||||
| net cash from operating activities | 8,246,000 | -13,256,000 | 1,108,000 | ||||||
| cash flows used in investing activities: | |||||||||
| cash flows from financing activities | |||||||||
| proceeds from issuance of notes payable | 0 | 0 | 125,000,000 | ||||||
| financing costs paid related to notes payable | -68,000 | 0 | -5,542,000 | ||||||
| distributions paid | -3,655,000 | ||||||||
| net cash from financing activities | 6,034,000 | -27,804,000 | 170,113,000 | ||||||
| net increase in cash, cash equivalents and restricted cash | 14,253,000 | -41,084,000 | 79,485,000 | ||||||
| cash, beginning of period | |||||||||
| issuance of common stock pursuant to distribution reinvestment plan | 1,242,000 | ||||||||
| net realized gain from investments | 968,000 | -503,000 | |||||||
| see “note 1 - organization and basis of presentation” and “note 12 - formation transactions”. | |||||||||
| net decrease in net assets resulting from operations: | -35,051,000 | ||||||||
| adjustments to reconcile net decrease in net assets resulting from | |||||||||
| operations to net cash from operating activities: | |||||||||
| accretion of original issue discounts and exit fees on investments | -2,074,000 | ||||||||
| depreciation | 9,000 | ||||||||
| borrowings under credit facility |
We provide you with 20 years of cash flow statements for Trinity Capital stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Trinity Capital stock. Explore the full financial landscape of Trinity Capital stock with our expertly curated income statements.
The information provided in this report about Trinity Capital stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.